Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
Assess the impact of steroid, diuretic, and fluid practices on BPD outcomes in extreme premature infants in the Banner - University Medical Center Phoenix (BUMCP) neonatal intensive care unit (NICU).
- BPD - Bronchopulmonary Dysplasia
- Eligible Ages
- All ages
- Eligible Genders
- Accepts Healthy Volunteers
- Infants born at <30 weeks and/or <1500g - Admitted to BUMCP between January 1, 2019 and December 31, 2020
- Infants that do not survive to 36 weeks CGA, when the determination of BPD is made - Infants that are transferred to another hospital prior to 36 weeks CGA - Out born infants - Infants with life threatening congenital anomalies - Investigator discretion as to other factors which might impact the study
- Study Type
- Observational Model
- Time Perspective
|Inclusion Group||Infants born at <30 weeks and/or <1500g that were admitted to BUMCP between January 1, 2019 and December 31, 2020||
- Mednax Center for Research, Education, Quality and Safety
Study ContactChristine Wade
The investigators propose performing a retrospective analysis of the current respiratory management methods to potentially find a correlation between the number of steroid doses administered, the timing of initiation of steroid therapy and the effect on premature infants at risk for developing BPD. The investigators are also going to explore the number and timing of diuretic medications and average fluid intake.